Respiratory Protection for Healthy Adults Exposed to Wood Smoke
(MASKON Trial)
Trial Summary
Do I need to stop taking my current medications for the trial?
Yes, you will need to stop taking certain medications for the trial. You cannot take any prescription or over-the-counter medications (except birth control) for one week before the bronchoscopy. Additionally, you must stop taking dietary supplements, vitamins, Omega-3 supplements, prebiotics, probiotics, and antihistamines for the duration of the study.
What data supports the effectiveness of the treatment NIOSH certified N95 personal face covering (mask) and Surgical Mask for healthy adults exposed to wood smoke?
Research shows that N95 masks can significantly reduce exposure to harmful particles in the air, like those found in wood smoke, by more than 14 times. Surgical masks also help, but to a lesser extent, reducing exposure by about 1.7 times. This means wearing these masks can lower the risk of respiratory issues when exposed to wood smoke.12345
Are N95 and surgical masks safe for humans?
How does using N95 and surgical masks as a treatment for wood smoke exposure differ from other treatments?
Using N95 and surgical masks for wood smoke exposure is unique because it involves wearing protective face coverings to filter out harmful particles from the air, unlike other treatments that might focus on medication or other interventions. N95 masks, in particular, offer significant protection by reducing exposure to particulate matter by more than 14 times, which is more effective than surgical masks and other types of face coverings.25101112
What is the purpose of this trial?
Purpose: This study is designed to test whether the gaseous fraction of woodsmoke, volatile organic compounds, produce acute cardiac, respiratory, and systemic inflammatory health effects after controlled exposure to woodsmoke in health, young volunteers.Participants: Approximately fifty, 18-35 year-old healthy volunteers to complete the study.Procedure: After consenting to participate in the study, participants will undergo two exposures to approximately 500 μg/m3 woodsmoke. The two exposures will be held at least 3 weeks apart. Each exposure session will have a follow-up session approximately 24 hr later. During each exposure session, participants will wear a modified MAXAir Systems (Irvine, CA, USA) (TC 21C-1050) controlled air pressure respirator (CAPR) that will deliver filtered woodsmoke directly to the participant's breathing zone. During the first exposure, the CAPR will deliver woodsmoke from which virtually all particulate matter (PM) and volatile organic compounds (VOC's) will be removed. During the second exposure, only the PM will be removed from the woodsmoke, allowing the VOC to pass into the subject's breathing zone. During each session, participants will be exposed for 2 hours while exercising intermittently (15 min exercise followed by 15 min rest) on a stationary bike at a workload sufficient to maintain a minute ventilation of approximately 25 L/min/m2. Venous blood samples and measurements of respiratory, cardiac, and vascular function will be performed prior, immediately following and approximately 18 hrs post each exposure. Approximately 24 hours post-exposure, participants will undergo a bronchoscopy procedure to sample bronchoalveolar fluid and cells for evidence of an inflammatory response to the exposures. Nasal epithelial lining fluid will be also collected approximately 24 hours post each exposure.
Research Team
James Samet, PhD
Principal Investigator
Environmental Protection Agency (EPA)
Eligibility Criteria
The MASKON trial is for young, healthy adults aged 18-35 with normal lung and heart function. Participants must have a BMI between 19 and 30, be able to do mild exercise on a bike, and be fully vaccinated against COVID-19.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Exposure Session 1
Participants undergo the first exposure to woodsmoke with virtually all particulate matter and volatile organic compounds removed, while exercising intermittently.
Follow-up Session 1
Participants are monitored for health effects approximately 24 hours after the first exposure, including bronchoscopy and nasal epithelial lining fluid collection.
Exposure Session 2
Participants undergo the second exposure to woodsmoke with only particulate matter removed, allowing volatile organic compounds to pass, while exercising intermittently.
Follow-up Session 2
Participants are monitored for health effects approximately 24 hours after the second exposure, including bronchoscopy and nasal epithelial lining fluid collection.
Final Follow-up
Participants are monitored for safety and effectiveness after the completion of both exposure sessions.
Treatment Details
Interventions
- NIOSH certified N95 personal face covering (mask)
- Surgical Mask
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Environmental Protection Agency (EPA)
Collaborator